XARELTO junior 51.7mg rivaroxaban susp 1 mg/ml fl
7680677010019
CH-67701
B01AF01
06.03.0.
bing
Details
- Product number
- 6770101
- CPT
- -
- Packaging group
- 1
- Unit
- Flasche(n)
- Composition
- rivaroxabanum 1.0 mg, acidum citricum, hypromellosum, mannitolum, cellulosum microcristallinum et carmellosum natricum, E 211 1.8 mg, sucralosum, xanthani gummi, aromatica, maltodextrinum, propylenglycolum, acaciae gummi, ad granulatum corresp. suspensio reconstituta 1 ml corresp. natrium 0.5 mg.
Articles (1)
Xarelto junior, Granulat zur Herstellung einer Suspension zum Einnehmen
Granulat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.8 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.5 MG | Substance | HBESI |
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 67701
- Drug name
- Xarelto junior, Granulat zur Herstellung einer Suspension zum Einnehmen
- Galenic form
- GRAS
- ATC Code
- B01AF01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 02/06/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 06.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XARELTO junior 51.7mg rivaroxaban susp 1 mg/ml fl
- Description (DE)
- XARELTO junior 51.7mg Rivaroxaban Susp 1 mg/ml Fl
- Market launch
- 02/06/2021
- Narcotic (BTM)
- No